Sonro continuous BTK inhibitors Podcasts — Companies Discussing Sonro continuous BTK inhibitors in Earnings Calls & Investor Presentations

BeOne Medicines AG Announced Q1 2026 Earnings on May 6, 2026, Reporting "Product revenue reached $1.5 billion in the quarter" artwork

BeOne Medicines AG Announced Q1 2026 Earnings on May 6, 2026, Reporting "Product revenue reached $1.5 billion in the quarter"

BeOne Medicines AG (ONC)

May 8, 2026 • 20:59 •Ep 149 •The Earnings Debate •▶ Play on Apple